Compounds to treat alzheimer's disease

Details Compounds to treat alzheimer's disease Compounds to treat alzheimer's disease

2005-01-25

2005-01-25

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252120, C514S616000, C514S617000, C544S358000, C544S398000, C544S402000

Reexamination Certificate

active

06846813

ABSTRACT:
The present invention is disubstituted amines of formula (I)and disubstituted amines of formula (II)useful in treating Alzheimer's disease and other similar diseases.

REFERENCES:
patent: 4224179 (1980-09-01), Schneider
patent: 4231877 (1980-11-01), Yamauchi et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4247411 (1981-01-01), Vanlerberghe et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4636491 (1987-01-01), Bock et al.
patent: 4665193 (1987-05-01), Ryono et al.
patent: 4668770 (1987-05-01), Boger et al.
patent: 4673567 (1987-06-01), Jizomoto
patent: 4676980 (1987-06-01), Segal et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4749792 (1988-06-01), Natarajan et al.
patent: 4753788 (1988-06-01), Gamble
patent: 4814270 (1989-03-01), Piran
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4880781 (1989-11-01), Hester, Jr. et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 5010182 (1991-04-01), Brake et al.
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5162538 (1992-11-01), Voges et al.
patent: 5175281 (1992-12-01), McCall et al.
patent: 5250565 (1993-10-01), Brooks et al.
patent: 5364934 (1994-11-01), Drayna et al.
patent: 5374652 (1994-12-01), Buzzetti et al.
patent: 5376542 (1994-12-01), Schlegal
patent: 5387742 (1995-02-01), Cordell
patent: 5441870 (1995-08-01), Seubert et al.
patent: 5461067 (1995-10-01), Norbeck et al.
patent: 5475138 (1995-12-01), Pal et al.
patent: 5481011 (1996-01-01), Chen et al.
patent: 5482947 (1996-01-01), Talley et al.
patent: 5502061 (1996-03-01), Hui et al.
patent: 5502187 (1996-03-01), Ayer et al.
patent: 5508294 (1996-04-01), Vazquez et al.
patent: 5510349 (1996-04-01), Talley et al.
patent: 5510388 (1996-04-01), Vazquez et al.
patent: 5516784 (1996-05-01), Bennett et al.
patent: 5521219 (1996-05-01), Vazquez et al.
patent: 5545640 (1996-08-01), Beaulieu et al.
patent: 5593846 (1997-01-01), Schenk et al.
patent: 5602169 (1997-02-01), Hewawasam et al.
patent: 5602175 (1997-02-01), Talley et al.
patent: 5604102 (1997-02-01), McConlogue et al.
patent: 5610190 (1997-03-01), Talley et al.
patent: 5612486 (1997-03-01), McConlogue et al.
patent: 5625031 (1997-04-01), Webster et al.
patent: 5631405 (1997-05-01), Pal et al.
patent: 5639769 (1997-06-01), Vazquez et al.
patent: 5648511 (1997-07-01), Ng et al.
patent: 5663200 (1997-09-01), Bold et al.
patent: 5708004 (1998-01-01), Talley et al.
patent: 5720936 (1998-02-01), Wadsworth et al.
patent: 5721130 (1998-02-01), Seubert et al.
patent: 5733882 (1998-03-01), Carr et al.
patent: 5744346 (1998-04-01), Chrysler et al.
patent: 5753652 (1998-05-01), Fässler et al.
patent: 5760064 (1998-06-01), Vazquez et al.
patent: 5760076 (1998-06-01), Vazquez et al.
patent: 5766846 (1998-06-01), Schlossmacher et al.
patent: 5807870 (1998-09-01), Anderson et al.
patent: 5807891 (1998-09-01), Bold et al.
patent: 5811633 (1998-09-01), Wadsworth et al.
patent: 5827891 (1998-10-01), Dressman et al.
patent: 5830897 (1998-11-01), Vazquez et al.
patent: 5831117 (1998-11-01), Ng et al.
patent: 5847169 (1998-12-01), Nummy et al.
patent: 5849911 (1998-12-01), Fassler et al.
patent: 5850003 (1998-12-01), McLonlogue et al.
patent: 5863902 (1999-01-01), Munoz et al.
patent: 5872101 (1999-02-01), Munoz et al.
patent: 5877015 (1999-03-01), Hardy et al.
patent: 5877399 (1999-03-01), Hsiao et al.
patent: 5912410 (1999-06-01), Cordell
patent: 5922770 (1999-07-01), Peschke et al.
patent: 5935976 (1999-08-01), Bold et al.
patent: 5942400 (1999-08-01), Anderson et al.
patent: 5962419 (1999-10-01), McDonald et al.
patent: 5965588 (1999-10-01), Vazquez et al.
patent: 6001813 (1999-12-01), Gyorkos et al.
patent: 6013658 (2000-01-01), Lau et al.
patent: 6022872 (2000-02-01), Vazquez et al.
patent: 6045829 (2000-04-01), Liversidge et al.
patent: 6051684 (2000-04-01), McDonald et al.
patent: 6060476 (2000-05-01), Vazquez et al.
patent: 6150344 (2000-11-01), Carroll et al.
patent: 6153652 (2000-11-01), Wu et al.
patent: 6191166 (2001-02-01), Audia et al.
patent: 6221670 (2001-04-01), Cordell et al.
patent: 20020016320 (2002-02-01), Fang et al.
patent: 3610593 (1987-10-01), None
patent: 3721 855 (1988-09-01), None
patent: 40 03 576 (1991-08-01), None
patent: 0 036776 (1981-09-01), None
patent: 0 073 657 (1983-03-01), None
patent: 0 117 058 (1984-08-01), None
patent: 0 117 060 (1984-08-01), None
patent: 0 173 441 (1986-05-01), None
patent: 0 209 897 (1987-01-01), None
patent: 0 212 903 (1987-03-01), None
patent: 0 264 106 (1988-04-01), None
patent: 0 274 259 (1988-07-01), None
patent: 0 320 205 (1989-06-01), None
patent: 0 337 714 (1989-10-01), None
patent: 0 362 179 (1990-04-01), None
patent: 0 372 537 (1990-06-01), None
patent: 0 437 729 (1991-07-01), None
patent: 0 609 625 (1994-08-01), None
patent: 0 652 009 (1995-05-01), None
patent: 2 203 740 (1988-10-01), None
patent: 2 211 504 (1989-07-01), None
patent: 7-126286 (1995-05-01), None
patent: 9509843 (1995-02-01), None
patent: WO 0110387 (2001-02-01), None
patent: WO 0151659 (2001-07-01), None
Chemical Abstract DN 123:169523, also cited as WO 9509843.*
Abbenante, et al.,Biochemical and Biophysical Research Communications,2000, 268, pp. 133-135 Inhibitors of β-Amyloid Formation Based on the β-Secretase Cleavage Site [439].
Alterman et al.,J. Med. Chem,1998, 41, 3782-3792 Design and Synthesis of New Potent C3-Symmetric HIV-1 Protease Inhibitors, Use of L-Mannaric Acid asa Peptiodomimetic Scaffold [868].
Amblard et al.,J. Med. Chem.,1999, 42:20, pp. 4193-4201 Synthesis and Characterization fo Bradykinin B2Receptor Agonists Containing Constrained Dipeptide Mimics [730].
Arrowsmith et al.,Tetrahedron Letters,1987, 28:45, pp. 5569-5572 Amino-Alcohol Dipeptide Analogues: A Simple Synthesis of a Versatile Isostere for the Development of Proteinase Inhibitors [584].
Askin et al.,The Journal of Organic Chemistry,1992, 57:10, pp. 2771-2773 Highly Disastrous Alkylations of Chiral Amide Enolates: New Routes to Hydroxyethylene Dipeptide Isostere Inhibitors of HIV-1 Protease [561].
Balicki et al.,Synth. Comm.,1993, 23(22), pp. 3149-3155 Mild and Efficient Conversion of Nitriles to Amides with Basic Urea-Hydrogen Peroxide Adduct [874].
Barton,Protective Groups in Organic Chemistry,1976, Chpt. 2, pp. 43-93 Protection of N-H Bonds and NR3[718].
Basu et al.,Tetrahedron Letters,1998, 39, pp. 3005-3006 Efficient Transformation of Nitrile into Amide under Mild Condition [881].
Bennett et al.,Synlett,1993, 9, pp. 703-704 The Synthesis of Novel HIV-Protease-Inhibitiors via Silica Gel Asisted-Addition of Amines to Epoxides [744].
Berge et al.,Journal of Pharmaceutical Sciences,1/1977, 66:1, pp. 1-19 Pharmaceutical Salts [735].
Blatt,Organic Syntheses,Collective vol. 2, pp. 312-315 Heptaldoxime [883].
Bodendorf et al.,The Journal of Biological Chemistry,2001, 276:15, pp. 12019-12023 A Splice Variant of β-Secretase Deficient in the Amyloidogenic Processingsof the Amyloid Precursor Protein [493].
Lin et al.,PNAS,2000, 97:4, pp. 1456-1460 Human Aspartic Protease Memapsin 2 Cleaves the β-Amyloid Precursor Protein [687].
Luly et al.,Journal of Organic Chemistry,1987, 52:8, pp. 1487-1492 A Synthesis of Protected AminoalkylEpoxides from Alpha Amino Acids [558].
Luo et al.,Nature Neuroscience,Mar. 2001, 4:3, pp. 231-232 Mice Deficient in BACE1, the Alzheimer's β-secretase have Normal Phenotype and Abolishedβ-amyloid Generation [210].
March,Advanced Organic Chemistry: Reactions, Mechanisms, and Structure3d Ed., pp. 380-381 Aliphatic Nucleophilic Substitution [729].
Martin et al.,Tetrahedron Letters,1998, 39, pp. 1517-1520 Apllication of Almez-Mediated Amidation Reactions to Solution Phase Peptide Synthesis [540].
Mashraqui et al.,J. Am. Chem. Soc.,1982, 104, pp. 4461-4465 Cyclophanes. 14. Synthesis, Structure Assignment, and Conformational Properties of [2.2](2,5)Oxazolo- and Thiazolophanes [872].
McLendon et al.,

Affiliated with

Also associated with

Rating

Compounds to treat alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds to treat alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds to treat alzheimer's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3432802